Peripheral Neuropathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with type 2 diabetes
- People between the ages of 50 and 75
- People of any gender (male or female)
- People who have had diabetes for more than 5 years
- People who screen positive on a standard nerve damage assessment tool called the Michigan Neuropathy Screening Instrument
- People who score above 20 on a balance assessment called the Berg Balance Scale, indicating at least some ability to maintain balance
Who may not be able to join:
- People who have had surgery on their knee, ankle, or hip joints
- People who have foot ulcers or foot deformities
- People who have been diagnosed with a neurological condition other than diabetic nerve damage — for example, stroke, multiple sclerosis, or Parkinson's disease
- People who have significant vision impairment or hearing loss (confirm with trial site)
- People who have difficulty understanding instructions
- People who have a physical disability that would prevent them from being able to carry out the exercises involved in the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +92 3325920425
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Balance; Fear of fall; Balance; Sensory function
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.